Immunogenicity of the conjugate and polysaccharide pneumococcal vaccines in high-risk renal patients.

Trial Profile

Immunogenicity of the conjugate and polysaccharide pneumococcal vaccines in high-risk renal patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Pneumococcal vaccine conjugate; Pneumococcal vaccines
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Sponsors Wyeth
  • Most Recent Events

    • 13 Aug 2010 United Kingdom Clinical Research Network reports accrual to date as 150%; this was identified via CA tool.
    • 13 Aug 2010 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
    • 13 Aug 2010 Planned end date changed from 16 Apr 2008 to 18 Apr 2008 as reported by UKCRN.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top